Cargando…

Repurposing drugs to fast-track therapeutic agents for the treatment of cryptococcosis

Many infectious diseases disproportionately affect people in the developing world. Cryptococcal meningitis is one of the most common mycoses in HIV-AIDS patients, with the highest burden of disease in sub-Saharan Africa. Current best treatment regimens still result in unacceptably high mortality rat...

Descripción completa

Detalles Bibliográficos
Autores principales:	Truong, Megan, Monahan, Leigh G., Carter, Dee A., Charles, Ian G.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	PeerJ Inc. 2018
Materias:	Microbiology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5937474/ https://www.ncbi.nlm.nih.gov/pubmed/29740519 http://dx.doi.org/10.7717/peerj.4761

Ejemplares similares

Drug Repurposing, a Fast-Track Approach to Develop Effective Treatments for Glioblastoma
por: Ntafoulis, Ioannis, et al.
Publicado: (2022)

Repurposing celecoxib as a topical antimicrobial agent
por: Thangamani, Shankar, et al.
Publicado: (2015)

A new culture medium for recovering the agents of Cryptococcosis from environmental sources
por: Silva, Dulcilena de Matos Castro e, et al.
Publicado: (2015)

Drug Repurposing for the Treatment of Bacterial and Fungal Infections
por: Miró-Canturri, Andrea, et al.
Publicado: (2019)

Repurposing Candesartan Cilexetil as Antibacterial Agent for MRSA Infection
por: Xu, Lanlan, et al.
Publicado: (2021)

Repurposing Antispasmodic Agent Otilonium Bromide for Treatment of Staphylococcus aureus Infections
por: Zhou, Linying, et al.
Publicado: (2020)

Repurposing FDA-approved drugs as therapeutics to treat Rift Valley fever virus infection
por: Benedict, Ashwini, et al.
Publicado: (2015)

Influenza A Virus as a Predisposing Factor for Cryptococcosis
por: Oliveira, Lorena V. N., et al.
Publicado: (2017)

Drug repurposing as an alternative for the treatment of recalcitrant bacterial infections
por: Rangel-Vega, Adrián, et al.
Publicado: (2015)

Corrigendum: Drug Repurposing for the Treatment of Bacterial and Fungal Infections
por: Miró-Canturri, Andrea, et al.
Publicado: (2022)

Drug Repurposing of the Alcohol Abuse Medication Disulfiram as an Anti-Parasitic Agent
por: Shirley, Debbie-Ann, et al.
Publicado: (2021)

Repurposing Eltrombopag as an Antimicrobial Agent Against Methicillin-Resistant Staphylococcus aureus
por: She, Pengfei, et al.
Publicado: (2022)

Identification of Hypericin as a Candidate Repurposed Therapeutic Agent for COVID-19 and Its Potential Anti-SARS-CoV-2 Activity
por: Matos, Aline da Rocha, et al.
Publicado: (2022)

The Repurposing of Anti-Psychotic Drugs, Quetiapine and Olanzapine, as Anti-Cryptococcus Drugs
por: Ogundeji, Adepemi O., et al.
Publicado: (2017)

Amlodipine and lufenuron as repurposing drugs against Sporothrix brasiliensis
por: Poester, Vanice Rodrigues, et al.
Publicado: (2023)

Repurposing Auranofin, Ebselen, and PX-12 as Antimicrobial Agents Targeting the Thioredoxin System
por: May, Holly C., et al.
Publicado: (2018)

In silico studies on therapeutic agents for COVID-19: Drug repurposing approach
por: Shah, Bhumi, et al.
Publicado: (2020)

Repurposing and Revival of the Drugs: A New Approach to Combat the Drug Resistant Tuberculosis
por: Sharma, Divakar, et al.
Publicado: (2017)

Drug Repurposing for Paracoccidioidomycosis Through a Computational Chemogenomics Framework
por: de Oliveira, Amanda Alves, et al.
Publicado: (2019)

Repurposing drugs with specific activity against L-form bacteria
por: Emami, Kaveh, et al.
Publicado: (2023)

Vaccine and Immunotherapeutic Approaches for the Prevention of Cryptococcosis: Lessons Learned from Animal Models
por: Hole, Camaron R., et al.
Publicado: (2012)

Grocott Methenamine Silver Staining Is the Optimal Approach to Histological Diagnosis of Pulmonary Cryptococcosis
por: Wang, Suijing, et al.
Publicado: (2022)

Repurposing non-antifungal drugs auranofin and pentamidine in combination as fungistatic antifungal agents against C. albicans
por: Lin, Jiaying, et al.
Publicado: (2022)

The Antifungal Activity of Lactoferrin and Its Derived Peptides: Mechanisms of Action and Synergy with Drugs against Fungal Pathogens
por: Fernandes, Kenya E., et al.
Publicado: (2017)

Repurposing the Sphingosine-1-Phosphate Receptor Modulator Etrasimod as an Antibacterial Agent Against Gram-Positive Bacteria
por: Zore, Matej, et al.
Publicado: (2022)

Repurposing and Reformulation of the Antiparasitic Agent Flubendazole for Treatment of Cryptococcal Meningoencephalitis, a Neglected Fungal Disease
por: Nixon, Gemma L., et al.
Publicado: (2018)

The Case for Adopting the “Species Complex” Nomenclature for the Etiologic Agents of Cryptococcosis
por: Kwon-Chung, Kyung J., et al.
Publicado: (2017)

Drug repurposing against COVID-19: focus on anticancer agents
por: Ciliberto, Gennaro, et al.
Publicado: (2020)

Drug Repurposing of Metabolic Agents in Malignant Glioma
por: Seliger, Corinna, et al.
Publicado: (2018)

Repurposing old drugs as antiviral agents for coronaviruses
por: Yang, Cheng-Wei, et al.
Publicado: (2020)

Host Molecules Regulating Neural Invasion of Zika Virus and Drug Repurposing Strategy
por: Tan, Li Yin, et al.
Publicado: (2022)

Statins as Potential Chemoprevention or Therapeutic Agents in Cancer: a Model for Evaluating Repurposed Drugs
por: Joharatnam-Hogan, Nalinie, et al.
Publicado: (2021)

Antimicrobial Activity of Non-steroidal Anti-inflammatory Drugs on Biofilm: Current Evidence and Potential for Drug Repurposing
por: Paes Leme, Rodrigo Cuiabano, et al.
Publicado: (2021)

Cryptococcosis
por: Haley, Lenore D.
Publicado: (1957)

Cryptococcosis
por: Maziarz, Eileen K., et al.
Publicado: (2014)

Cryptococcosis
por: Forrestel, Amy K.
Publicado: (2018)

Diagnostic and therapeutic strategies in cryptococcosis: impact on outcome
por: Chammard, Timothée Boyer, et al.
Publicado: (2018)

Genomic Polymorphisms as Inherent Watermarks for Tracking Infectious Agents
por: Jupiter, Daniel, et al.
Publicado: (2010)

Repurposing of statins for Buruli Ulcer treatment: antimicrobial activity against Mycobacterium ulcerans
por: Dominguez, Juan, et al.
Publicado: (2023)

Repurposed agents in the Alzheimer’s disease drug development pipeline
por: Bauzon, Justin, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_6p7bac8vqkmcfbbum7kqum9pfb